Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospira, now a wholly owned subsidiary of Pfizer
Patients will be randomly assigned to PMI-150 (intranasal ketamine) or placebo and will receive repeated doses and be assessed for safety and efficacy.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
patient is scheduled for elective orthopedic surgery or procedure
You may not be if
patient has received an investigational drug or participated in a clinical trial within 30 days or 5 half-lives (whichever is longer) of entering this study
Clareo Health | Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery
